Reveal Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Reveal Biosciences, Inc. - overview
Established
2012
Location
San Diego, CA, US
Primary Industry
Biotechnology
About
Founded in 2012 and based in California, US, Reveal Biosciences, Inc. is a computational pathology company focused on tissue-based research that combines traditional histopathology and artificial intelligence to deliver actionable data. The company was founded by its CEO Claire Weston and CTO Casey Laris. In April 2019, Reveal Biosciences, Inc.
raised an undisclosed amount of Series A funding led by new investor Intel Capital, with participation from other new investors GNI Ltd. and PP Capital. As of 2019, the company has around 25 employees. Reveal Biosciences combines artificial intelligence with pathology to diagnose disease from large whole-slide microscope images.
The company’s proprietary deep-learning platform, ImageDx™, provides pathologists and scientists a novel class of actionable, quantitative data from their whole-slide pathology images by increasing its accuracy, reproducibility, and scale to advance their research and enhance patient care. The company's services include computational diagnostics, companion diagnostics, clinical trials, patient stratification, disease diagnosis, tumor detection, and automated NASH. The company also provides biopharma assay services such as advanced tissue processing, staining, and analysis. Reveal Biosciences plans to expand its ImageDx™ online software platform with a pipeline of AI-based decision support tools.
Current Investors
Arsenal Capital Partners, CellCarta Inc.
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Healthcare IT, Analytics & Performance Software
Website
www.revealbio.com
Verticals
Artificial Intelligence, Artificial Intelligence, HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Reveal Biosciences, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Reveal Biosciences, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.